Nose | |||||
---|---|---|---|---|---|
Nose / Nasal congestion | |||||
ephedrine hydrochloride | On Formulary | ||||
pseudoephedrine hydrochloride | On Formulary | ||||
xylometazoline hydrochloride | On Formulary | ||||
Spray | |||||
Otrivine (Haleon UK Trading Ltd) | On Formulary | ||||
Nose / Nasal infection | |||||
betamethasone with neomycin | On Formulary | ||||
chlorhexidine with neomycin | On Formulary | ||||
mupirocin | On Formulary | ||||
Nasal ointment | |||||
Bactroban (GlaxoSmithKline UK Ltd) | On Formulary | ||||
Nose / Nasal inflammation, nasal polyps and rhinitis | |||||
azelastine hydrochloride | On Formulary | ||||
beclometasone dipropionate | On Formulary | ||||
Spray | |||||
Beclometasone dipropionate (Non-proprietary) | On Formulary | ||||
Beconase (GlaxoSmithKline UK Ltd, Omega Pharma Ltd) | On Formulary | ||||
Nasobec (Teva UK Ltd) | On Formulary | ||||
betamethasone | On Formulary | ||||
Betesil Medicated Plaster - Inflammatory Skin Disorders (November 2022)
Approved at NEL FPG (Nov 2022) Betesil® 2.250mg medicated plaster is the only potent corticosteroid indicated in adults for the treatment of inflammatory skin disorders. The plaster is licensed to use for a maximum of 30 days at a time, with a maximum of 6 plasters being used at any one time. Plasters may be changed once every 24 hours. Amber-may be prescribed by or on the advice of a specialist |
|||||
budesonide | On Formulary |
NICE TA708 NICE TA937 |
|||
NICE TA 937 -March 2024- Budesonide treating for primary IgA nephropathy (HCD)
Budesonide approved at NEL FPG treating for primary IgA nephropathy (HCD)
Formulary Status: Hospital Only |
|||||
Budesonide orodispersible tablets
Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis as per NICE TA708 Approved as Hospital Only. September 2021 DTC. |
|||||
desloratadine | Off Formulary | ||||
fexofenadine hydrochloride | On Formulary | ||||
fluticasone | On Formulary | ||||
Spray | |||||
Fluticasone (Non-proprietary) | On Formulary | ||||
Allergic Rhinitis Pathway
Allergic Rhinitis Pathway |
|||||
FLUTICASONE PROPIONATE
Moderate to severe symptoms of allergic rhinitis-refer to treatment algorithm for further details |
|||||
fluticasone with azelastine | On Formulary | ||||
ipratropium bromide | On Formulary | ||||
ketotifen | Off Formulary | ||||
mometasone furoate | On Formulary | ||||
rupatadine | Off Formulary | ||||
triamcinolone acetonide | On Formulary |